AzTrials
AzTrials

StrokeNCT03832413

Characterization of the DELPhI System in Assessing Brain's Functionality in Different Neurological Disorders

An observational study of Stroke and TBI, run by QuantalX Neuroscience at 1 site in Israel.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

We use Transcranial magnetic stimulation (TMS), combined with simultaneous registration of electroencephalograph (EEG),for examining human cortical functionality. TMS-EEG is a noninvasive brain stimulation method that allows to study human cortical function in vivo. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Stroke, TBI, Fibromyalgia
What is being tested?
DELPhI (TMS-EEG analysis)
How many people
193 participants
Where
1 siteIsrael
Study dates
23 Apr 2018to 14 Feb 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Patients arriving to the Sagol center for Hyperbaric medicine at Assaf harofe Medical center, undergoing a series of hyperbaric treatment sessions and will be found compatible to inclusion/exclusion criteria.

Who may be able to join

  • Man and woman at the ages of ≥18 years.
  • Designated to perform a neurocognitive evaluation at the Sagol center for hyperbaric medicine and research, at Assaf-Harofe Medical center.

Who cannot join

  • Under 18 years of age.
  • With a skin condition on the scalp preventing the placement of EEG cap.
  • Pregnant or breastfeeding woman.
  • Unable to give an informed consent.

Trial locations and contacts

1 site in 1 country.

Israel1 site
  • Asaf-Harophe

    Rishon LeZiyyon, 70300

Other trials in Israel

About this study

Official title: Characterization of the DELPhI System in Assessing Brain's Functionality in Different Neurological Disorders-A Pilot Study

We use Transcranial magnetic stimulation (TMS), combined with simultaneous registration of electroencephalograph (EEG),for examining human cortical functionality. TMS-EEG is a noninvasive brain stimulation method that allows to study human cortical function in vivo. EEG provides an opportunity to directly measure the cerebral response to TMS, measuring the cortical TMS Evoked potential (TEP). In this study we measure TEPs, in a wide variety of neurological conditions and healthy as a measure of cerebral reactivity across wide areas of neocortex.

Read the detailed description

Brain network plasticity evaluation has been shown extensively essential for understanding and monitoring of brain functional changes and brain disorders. However, existing clinically used imaging methods are unable to robustly indicate plasticity or plasticity changes. Therefore, there is a great need for developing such an imaging tool for brain functional evaluation. In basic neuroscience research plasticity evaluation is performed by conducting electrophysiological measurements in vivo. By using EEG - combined with TMS stimulation this methodology can be transformed into clinically used plasticity and connectivity assessment for evaluation of functional brain status. This study may thus introduce a novel, non-invasive and efficient method for brain functional imaging. DELPhI evaluation will offer a true multimodality imaging by combining EEG and TMS that allows a quantative objective and direct identification of disease assessment. There is a real unmet need for an accurate and objective evaluation that together with the common clinical practice will provide neurologists and psychiatrists a more definite and personalized treatment prescription.

Studies integrating TMS with EEG (TMS-EEG) have shown that TMS produces waves of activity that reverberate throughout the cortex and that are reproducible and reliable thus providing direct information about cortical excitability and connectivity with excellent time resolution. By evaluating the propagation of evoked activity in different behavioral states and in different tasks, TMS-EEG has been used to causally probe the dynamic effective connectivity of human brain networks. When applying the TMS coil above the motor cortex, a cascade effect called the motor-evoked potential (MEP), is initiated. The MEP is measurable at peripheral muscles. The Motor cortex is a brain structure located between the frontal and parietal cortices. Pyramidal neurons in the motor cortex, upper motor neuron going through the brain stem, send signals to lower motor neuron in the spinal cord which stimulate muscle fibers. TMS stimulus to the Motor cortex evokes a brain response which propagates to different brain regions in addition to the peripheral limb muscles [20]. An important feature of TEP topography is that even though only one cortical hemisphere is stimulated, bihemispheric EEG evoked responses are evoked with different features. TMS-evoked activity propagates from the stimulation site ipsilaterally via association fibers and contralaterally via transcallosal fibers and to subcortical structures via projection fibers. These TMS-evoked cortical potentials (TEPs) last for up to 300 ms in both the vicinity of the stimulation as well as in remote interconnected brain areas reflect long term changes in cortical network excitation-inhibition balance refeed to as brain network plasticity. A single TMS pulse delivered over the primary motor cortex (M1) results in a sequence of positive and negative EEG peaks at specific latencies (i.e., P25, N45, P70, N100, and P180).

In this study a wide population of subjects will be recruited. this population will include different neurological conditions and healthy subjects, arriving to the Hyperbaric center at Asaf-Harophe hospital. Each subject will be tested once before treatment initiation and subsequent tests will be performed also after treatment termination or at follow up time points. Each evaluation will last up to 90 minutes and will include affixed stimulation protocol ranging Up to 1000 TMS pulses, with intensities between 60-130% of motor threshold (MT). Inter-stimuli frequency will change from 0.01 up to 20 Hz.Existing clinical data such as MRI scans, neurocognitive assessments and clinical evaluations will be collected out of patient files. EEG data recorded will be analyzed and corrolations to the clinical data will be tested.

Being tested
DELPhI (TMS-EEG analysis)
Medical subject headings
Stroke, Fibromyalgia, Attention Deficit Disorder with Hyperactivity, Stress Disorders, Post-Traumatic, Dementia, Cognitive Dysfunction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • DELPhI (TMS-EEG analysis)Diagnostic test

    We perform an evaluation not an intervention. the DELPhI evaluation comprises of an automated analysis to EEG data recorded during TMS (Transcranial Magnetic Stimulation) to the M1L (Primary motor cortex).

Study groups in NCT03832413
Study groupRoleWhat they receive
StrokeDiagnostic Test: DELPhI (TMS-EEG analysis)
Receives: Diagnostic Test: DELPhI (TMS-EEG analysis)
TBIDiagnostic Test: DELPhI (TMS-EEG analysis)
Receives: Diagnostic Test: DELPhI (TMS-EEG analysis)
ABDDiagnostic Test: DELPhI (TMS-EEG analysis)
Receives: Diagnostic Test: DELPhI (TMS-EEG analysis)
FibromyalgiaDiagnostic Test: DELPhI (TMS-EEG analysis)
Receives: Diagnostic Test: DELPhI (TMS-EEG analysis)
PDDDiagnostic Test: DELPhI (TMS-EEG analysis)
Receives: Diagnostic Test: DELPhI (TMS-EEG analysis)
ADHDDiagnostic Test: DELPhI (TMS-EEG analysis)
Receives: Diagnostic Test: DELPhI (TMS-EEG analysis)
MCIDiagnostic Test: DELPhI (TMS-EEG analysis)
Receives: Diagnostic Test: DELPhI (TMS-EEG analysis)
DementiaDiagnostic Test: DELPhI (TMS-EEG analysis)
Receives: Diagnostic Test: DELPhI (TMS-EEG analysis)
HealthyDiagnostic Test: DELPhI (TMS-EEG analysis)
Receives: Diagnostic Test: DELPhI (TMS-EEG analysis)
Cognitive impairmentDiagnostic Test: DELPhI (TMS-EEG analysis)
Receives: Diagnostic Test: DELPhI (TMS-EEG analysis)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Correlation between DELPhI's parameters to MRI scans

    Correlation between DELPhI parameters to cognitive assessment by MRI/CT and computerized cognitive evaluation (Mindstreems cognitive battery test).

    Measured: through study completion, an average of 1 year

  2. Correlation between DELPhI's parameters to cognitive assessment

    Correlation between DELPhI parameters to MRI/CT and computerized cognitive evaluation (Mindstreems cognitive battery test).

    Measured: through study completion, an average of 1 year

Secondary outcomes (1)
  1. Cluster TMS Evoked Responses' (TEPs') features such as amplitude, latency, Area under the curve and slopes.

    Calculating potential clusters based on TEP's features at different stimulation conditions. Features such as amplitude, area under the curve, slope and latency.

    Measured: through study completion, an average of 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Feb 2019
  2. Study start23 Apr 2018
  3. Primary completion14 Feb 2022
  4. Study completion14 Feb 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
193 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03832413
Sponsor's protocol ID
QuantalX_pilot_asaf_harophe
Status last verified
Feb 2019
First submitted
1 Nov 2018
Last updated
16 Feb 2022
Results posted
No
FDA-regulated device
Yes

Questions about this trial

What is this clinical trial studying?

An observational study of Stroke and TBI, run by QuantalX Neuroscience at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Feb 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Correlation between DELPhI's parameters to MRI scans (time frame: through study completion, an average of 1 year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Feb 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT03832413 | AzTrials